Efficacy and safety of remimazolam combined with remifentanil for sedation during awake fiberoptic intubation: a randomized controlled trial
Introduction There has been not study determining if remimazolam combined with remifentanil is the reasonable dosing regimen for sedation during awake fiberoptic intubation (AFOI). This prospective double-blind randomized controlled trial compare efficacy and safety of sedation using different-dose...
Saved in:
Main Authors: | Xiao-Rui Zhou, Cheng-Wen Li, Kai Su, Yi Cheng, Mu Jin, Fu-Shan Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2527951 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remifentanil enhances the sedative effect of remimazolam during anesthesia induction in patients undergoing hysteroscopy: a randomized controlled trial
by: Zhengui Xie, et al.
Published: (2025-12-01) -
FIBEROPTIC TRACHEA INTUBATION
by: A. V. Mironov, et al.
Published: (2018-01-01) -
Comparative efficacy of different doses of dexmedetomidine in sedation during awake fibreoptic nasotracheal intubation: A systematic review and meta-analysis
by: Mohd Ovais Alam, et al.
Published: (2025-07-01) -
Remimazolam, a novel drug, for safe and effective endoscopic sedation
by: Jae Min Lee, et al.
Published: (2025-05-01) -
Dexmedetomidine vs. midazolam-ketamine for sedation during awake fiberoptic nasal intubation in patients with difficult airway - A randomized, double-blinded, comparative trial
by: R Sivakumar, et al.
Published: (2025-07-01)